Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/17/24 16:03 | 1/10/24 | COEP | Health | BioPrd | Biological Products, (No Diag | Cogley Brian | PA | O | CFO | P | 3 | 0.6700 | 0 | 5 | 20 | 30 | D | ||||||||||||||
1/16/24 20:14 | 1/12/24 | COEP | Health | BioPrd | Biological Products, (No Diag | Desilva Tara | PA | D | P | 1 | 0.5759 | 0 | 2 | 8 | 32 | D | |||||||||||||||
1/9/24 17:32 | 1/5/24 | COEP | Health | BioPrd | Biological Products, (No Diag | Yerace Daniel Alexander | PA | DO | VP of Op | P | 7 | 0.6900 | 0 | 11 | 1 | 1,071 | D | ||||||||||||||
1/9/24 17:31 | 1/5/24 | COEP | Health | BioPrd | Biological Products, (No Diag | Salkind Gene | PA | D | P | 8 | 0.6900 | 0 | 12 | 4 | 317 | D | |||||||||||||||
1/9/24 17:30 | 1/5/24 | COEP | Health | BioPrd | Biological Products, (No Diag | Mehalick David | PA | DOT | CEO,P | P.m | 17 | 0.6684 | 0 | 25 | 1 | 2,783 | D | ||||||||||||||
1/9/24 17:30 | 1/5/24 | COEP | Health | BioPrd | Biological Products, (No Diag | Cochran Christopher P. | PA | D | P | 5 | 0.7700 | 0 | 7 | 23 | 37 | D | |||||||||||||||
8/31/23 16:01 | 8/23/23 | COEP | Health | BioPrd | Biological Products, (No Diag | Calise Chris | PA | D | P | 11 | 0.9393 | 0 | 12 | 1 | 1,465 | D | |||||||||||||||
8/30/23 15:15 | 8/25/23 | COEP | Health | BioPrd | Biological Products, (No Diag | Salkind Gene | PA | D | P.m | 30 | 0.9223 | 0 | 33 | 15 | 254 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |